The ASA urged Congress to introduce legislation that includes developing an early warning system for disruptions in drug production; requiring manufacturers to have contingency plans for raw materials suppliers; requiring collaboration between the FDA and Drug Enforcement Agency in establishing flexibility for product development and raw material quotas; and establishing incentives for manufacturers.
Related Articles on Anesthesia:
Medicare Updates of Interest to Anesthesiologists and Pain Physicians
Anesthesiologist Survey: Concern Over Blame From Colleagues a Barrier to Reporting Errors
Anesthesiologist Appointed to Medical College of Wisconsin Faculty
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.